Navigation Links
Timm Medical Technologies and Ferring Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Prosed(R) DS
Date:10/14/2009

MINNEAPOLIS, Oct. 14 /PRNewswire/ -- Timm Medical Technologies, Inc., a specialist Urology company, announced today its exclusive co-promotion agreement with Ferring Pharmaceuticals Inc., a Swiss-based biopharmaceutical company, for Prosed® DS (methenamine, phenyl salicylate, methylene blue, benzoic acid, hyoscyamine sulfate) in the United States.

Under the agreement, Timm Medical will be responsible for promoting Prosed® DS to urologists and retail pharmacists in the United States. Ferring will continue to promote Prosed® DS to physicians in the United States and will retain responsibility for manufacturing, supply and regulatory affairs. Financial terms of the agreement were not disclosed.

Prosed® DS is a urinary analgesic, antiseptic and antispasmodic combination. Prosed® DS has a long history of use for the treatment of pain and discomfort of the lower urinary tract.

"We are excited to partner with Ferring Pharmaceuticals to promote this well-established treatment for urinary discomfort," commented David Talen, President of Timm Medical. "Timm Medical and Ferring Pharmaceuticals share a commitment to urologists and the care of their patients. Timm Medical's flagship product, the Osbon ErecAid, has a 30-year history of providing safe, effective and reliable treatment for men suffering from erectile dysfunction. Prosed® DS has the same outstanding reputation as an effective treatment for the pain associated with urological procedures, inflammatory diseases and infections, and represents a natural complement to our product portfolio."

About Timm Medical

Timm Medical is a specialist urology company owned by affiliates of Paul Capital Healthcare. Timm Medical offers products in the areas of erectile function and incontinence. Through its sales force in the United States, Timm calls on over 3,000 urology practices. In addition, Timm distributes products via a 60+ international distributor network. For more information, contact David Talen, President or visit www.timmmedical.com.

About Ferring Pharmaceuticals Inc.

Ferring Pharmaceuticals Inc. is a subsidiary of Ferring Pharmaceuticals, a privately owned, international pharmaceutical company. Ferring Pharmaceuticals offers a line of infertility, urology, and orthopaedic products in the U.S. market. They include: BRAVELLE® (urofollitropin for injection, purified), MENOPUR® and REPRONEX® (menotropins for injection, USP), NOVAREL® (chorionic gonadotropin for injection, USP), ENDOMETRIN® (progesterone) Vaginal Insert, 100 mg, FIRMAGON® (degarelix for injection), PROSED® DS (methenamine, phenyl salicylate, methylene blue, benzoic acid, hyoscyamine sulfate), DESMOPRESSIN, and EUFLEXXA® (1% sodium hyaluronate).

Ferring Pharmaceuticals specializes in the research, development and commercialization of compounds in general and pediatric endocrinology, urology, orthopaedics, gastroenterology, obstetrics/gynecology, and infertility. For more information, call 1-888-FERRING (1-888-337-7464) or visit www.FerringUSA.com.

SOURCE Timm Medical Technologies, Inc.


'/>"/>
SOURCE Timm Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardiva Medical, Inc. Announces the Departure of its President and his Appointment as CEO of Innovative Energy, Inc.
2. Vibrant Exhibit Hall Features Innovative Medical Technology at AdvaMed 2009
3. Luminous Medical, Inc. Secures Exclusive Rights to Glucose Sensor for Its Automated Glucose Monitor
4. Growing Supply Chain Complexity Increasing Impact on Medical Device Company Operations
5. Award-Winning Medical Technology From Germany
6. Cantel Medicals Crosstex Subsidiary Launches New Specially Treated Face Mask Effective Against H1N1 Influenza
7. ATS Medical Announces Receipt of CE Mark for the New ATS CryoMaze 10-S Probe
8. Sonitus Medical Technology Ranks #1 on Cleveland Clinics Top 10 Medical Innovations for 2010
9. Medical Technology Executives Descend on D.C. as AdvaMed 2009: The MedTech Conference Kicks Off and Health Care Debate Continues
10. MDMA Board Unanimously Opposes Medical Device Tax
11. Fresenius Medical Care, N.A. Has Selected VitalRemedyMDs VitalProteinRx(TM) As Its Bar of Choice for Protein Replacement in Dialysis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... 18, 2017 ML Capital ... to publish an online presentation tomorrow, January 19 ... forecast for 2017. Management reports that the forecast ... sales performance from its existing operations, and the ... into the Cannabis sector through a partnership ...
(Date:1/18/2017)... 2017  Astellas Pharma Inc. (President and CEO: ... its participation in Access Accelerated, a global, multi-stakeholder ... prevention, diagnostics and treatment in low-income and lower-middle ... companies and in collaboration with the World Bank ... (UICC), Astellas will work towards the United Nations ...
(Date:1/17/2017)... Jan. 17, 2017 North America Insulin Delivery ... report, "North America Insulin Delivery Market Outlook to 2022", ... Delivery market. The report provides value, in millions of ... within market segments - Insulin Pens, Insulin Pumps, Insulin ... also provides company shares and distribution shares data for ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... January 18, 2017 , ... During pregnancy, women are ... erosion, and those dental problems can increase the risk of pregnancy complications. Unfortunately, ... are failing to get the dental care they need. Agoura Hills dentist, Philip ...
(Date:1/17/2017)... ... January 17, 2017 , ... Gym Source, America’s leading retailer ... showroom at South Dixie Hwy in Miami, FL. , “We are elated to be ... new innovative in-store concept is designed to give clients a seamless and motivating shopping ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... improved supplement, Healthful-Flex. , The company, owned and operated by Ed Stroup, ... at a reasonable price with the highest level of customer service. Healthful Balance ...
(Date:1/17/2017)... ... January 17, 2017 , ... Metro Development ... to infusing high speed technology into the fabric of an entire community. A ... of healthcare and wellness in a yet-to-be-named, health focused campus. Leading this initiative ...
(Date:1/17/2017)... ... January 17, 2017 , ... Peoples Health is pleased ... network on Dec. 1, 2016. Peoples Health, a Metairie-based Medicare Advantage company, serves ... exciting addition to our provider network, and the addition will benefit our members ...
Breaking Medicine News(10 mins):